OA
OmniAb, Inc.
OABIW · NASDAQ
$0.28 +7.69% (+$0.02)
1M +20.43%
Market Cap $40.6M
P/E Ratio -
Div. Yield -
ROE 16.59%
Bulios Fair Price
$0.23
17.9% downside
Current Price
$0.28
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OABIW is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.16x
P/S 1.06x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 7.86%
Rev. growth 31.89%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 125.80%
Gross margin 50.53%
FCF margin 47.20%
Quality
2 /100
Poor ROA 15.25%
ROIC 17.41%
Asset turnover 0.13x
Debt
100 /100
Low Current ratio 4.80x
Debt/Equity 0.07x
Debt/Assets N/A
Stability
53 /100
Moderate EPS volatility 53.38%
Beta 1.22x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OABIW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Matthew W. Foehr
Employees
89
Headquarters
EmeryVille
Upcoming events
17 NOV
Earnings
Upcoming earnings report